Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
fda
7
×
life sciences
7
×
national blog main
vc
7
×
wisconsin blog main
wisconsin top stories
7
×
national top stories
new york blog main
new york top stories
san diego blog main
san francisco blog main
biotech
boston blog main
boston top stories
boulder/denver blog main
boulder/denver top stories
detroit blog main
detroit top stories
indiana blog main
indiana top stories
national
raleigh-durham blog main
raleigh-durham top stories
san diego top stories
san francisco top stories
seattle blog main
seattle top stories
startups
texas blog main
texas top stories
biogen
deals
healthcare
ipo
national venture capital association
novartis
pitchbook
venture capital
wisconsin
celgene
What
bio
roundup
ipo
new
biogen
healthcare
investors
medical
startup
technology
years
activity
allogene
america
appear
approvals
bigger
biggest
biopharma
cancer
car
cash
celgene
clamped
colleagues
companies
competition
continue
continues
convoluted
covid
crispr
crucial
deal
deals
deerfield
delays
democrats
developing
didn't
Language
unset
Current search:
fda
×
vc
×
" life sciences "
×
" wisconsin top stories "
×
@xconomy.com
4 years ago
Bio Roundup: Fast FDA Approvals, Biogen Delays, ORIC’s IPO & More
@xconomy.com
5 years ago
Bio Roundup: Head and Spine Previews, Biogen Moves, IPO Dreams & More
@xconomy.com
5 years ago
NorthStar Secures $75M+ as Medical Radioisotope Competition Revs Up
@xconomy.com
5 years ago
After 33 Exits in 5 Years, WI Seeks “More and Bigger” Startup Deals
@xconomy.com
5 years ago
Bio Roundup: $74B for Celgene, Two CAR-T Tales, Ready for SF & More
@xconomy.com
5 years ago
After Deal Stalled, Shine Medical Eyeing Up to $160M from Deerfield
@xconomy.com
5 years ago
Bio Roundup: BIO Diversity, Allogene IPO, CRISPR In Utero & More